Clinical Trial Update: A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating systemic cisplatin added to intracavitary cisplatin versus placebo with intracavitary cisplatin for malignant pleural effusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Malignant Pleural Effusion | Phase 3 | Status: ACTIVE_NOT_RECRUITING